Inventor · disambiguated record
Denton W. Hoyer
Also filed as: HOYER DENTON · HOYER DENTON W · HOYER DENTON WADE
24 granted patents·15 pending applications·265 citations·filing 1994–2025
95Inventor score
Top patents by PatentIndex Score
39 records- 0191US10730862B2Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an E3 ubiquitin ligaseUNIV YALE·Filed 2013·Granted Aug 4, 2020·15 cites·14 claims
- 0289US9340493B2Hydroxamic acid derivatives useful as antibacterial agentsPFIZER·Filed 2014·Granted May 17, 2016·7 cites·16 claims
- 0387US5585357AHeteroaryloxymethyl ketones as interleukin-1βconverting enzyme inhibitorsSANOFI WINTHROP INC·Filed 1996·Granted Dec 17, 1996·69 cites·24 claims
- 0484US11896577B2Short-acting psychoactive compounds of the MDMA classMYDECINE INNOVATIONS GROUP INC·Filed 2023·Granted Feb 13, 2024·1 cites·6 claims
- 0583US6423727B1Certain thiol inhibitors of endothelin-converting enzymeNOVARTIS AG·Filed 2000·Granted Jul 23, 2002·12 cites·17 claims
- 0681US7196090B2Kinase inhibitorsWARNER LAMBERT CO·Filed 2003·Granted Mar 27, 2007·23 cites·10 claims
- 0779US5532150ALow diol polyalkylene oxide biologically active proteinaceous substancesSTERLING WINTHROP INC·Filed 1994·Granted Jul 2, 1996·34 cites·8 claims
- 0878US8722686B2Hydroxamic acid derivatives useful as antibacterial agentsBROWN MATTHEW F·Filed 2009·Granted May 13, 2014·5 cites·14 claims
- 0978US6613782B2Certain thiol inhibitors of endothelin-converting enzymeNOVARTIS AG·Filed 2002·Granted Sep 2, 2003·7 cites·2 claims
- 1077US11939292B1Aza-substituted psilocin analogs and methods of synthesizing the sameMYDECINE INNOVATIONS GROUP INC·Filed 2023·Granted Mar 26, 2024·0 cites·6 claims
- 1176US11952342B2Aza-substituted psilocin analogs and methods of synthesizing the sameMYDECINE INNOVATIONS GROUP INC·Filed 2023·Granted Apr 9, 2024·0 cites·3 claims
- 1274US11504373B2Compounds and compositions for treating fibrosisUNIV YALE·Filed 2018·Granted Nov 22, 2022·2 cites·12 claims
- 1374US2024335445A1Compounds and Compositions for Treating FibrosisUNIV YALE·Filed 2024·Application pending·0 cites
- 1474US2024317729A1Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin LigaseUNIV YALE·Filed 2024·Application pending·0 cites
- 1572US2024199543A1Aza-Substituted Psilocin Analogs And Methods Of Synthesizing The SameMYDECINE INNOVATIONS GROUP INC·Filed 2024·Application pending·0 cites
- 1671US12310970B2Compounds and methods for treating or preventing anterior segment ocular disorders and/or retinal degenerationsUNIV YALE·Filed 2023·Granted May 27, 2025·0 cites·10 claims
- 1771US5661020ALow diol polyalkylene oxide biologically active proteinaceous substancesSANOFI SA·Filed 1996·Granted Aug 26, 1997·26 cites·13 claims
- 1869US5677283Aα-heteroaryloxymethyl ketones as interleukin - 1 β converting enzyme inhibitorsSANOFI SA·Filed 1996·Granted Oct 14, 1997·26 cites·3 claims
- 1968US12064415B2Psilocin prodrug compounds and methods of synthesizing the sameMYDECINE INNOVATIONS GROUP INC·Filed 2023·Granted Aug 20, 2024·0 cites·16 claims
- 2068US6121266APyridazines as interleukin-1β converting enzyme inhibitorsVERTEX PHARMA·Filed 1995·Granted Sep 19, 2000·21 cites·8 claims
- 2168US2023181588A1Compounds and Compositions for Treating FibrosisUNIV YALE·Filed 2022·Application pending·0 cites
- 2268US2025276067A1Anticancer drugs and methods of making and using sameUNIV YALE·Filed 2024·Application pending·0 cites
- 2367US5985838APeptide analogs as irreversible interleukin-1β protease inhibitorsVERTEX PHARMA·Filed 1996·Granted Nov 16, 1999·8 cites·11 claims
- 2464US6576614B1Peptide analogs as irreversible interleukin-1β protease inhibitorsVERTEX PHARMA·Filed 1999·Granted Jun 10, 2003·7 cites·9 claims
- 2563US6995261B24-pyridazinecarboxamides and esters as interleukin-1β converting enzyme inhibitorsVERTEX PHARMA·Filed 2003·Granted Feb 7, 2006·1 cites·9 claims
- 2662US2025345441A1Anticancer drugs and methods of making and using sameUNIV YALE·Filed 2025·Application pending·0 cites
- 2758US11717521B2Compounds and methods for treating or preventing anterior segment ocular disorders and/or retinal degenerationsUNIV YALE·Filed 2020·Granted Aug 8, 2023·0 cites·9 claims
- 2857US2022088204A1Anticancer drugs and methods of making and using sameUNIV YALE·Filed 2020·Application pending·0 cites
- 2956US2025288588A1Substituted imidazopyridines and imidazopyrimidines, and use of same for treating, ameliorating, and/or preventing retinal degenerationUNIV YALE·Filed 2023·Application pending·0 cites
- 3055US12414927B2CXCR5 antagonists and methods of treating diseases or disorders using sameUNIV YALE·Filed 2021·Granted Sep 16, 2025·0 cites·15 claims
- 3154US2019127359A1Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin LigaseUNIV YALE·Filed 2018·Application pending·0 cites
- 3252US11746111B2Siderophore conjugated pyrazolidinones, and analogues thereofUNIV YALE·Filed 2019·Granted Sep 5, 2023·0 cites·17 claims
- 3351US2021085796A1Anticancer drugs and methods of making and using sameUNIV YALE·Filed 2018·Application pending·0 cites
- 3449US2004009923A1Peptide analogs as irreversible interleukin-1beta protease inhibitorsFiled 2003·Application pending·0 cites
- 3548US2023227439A1Spak/osr inhibitors and methods of using sameUNIV YALE·Filed 2020·Application pending·0 cites
- 3645US2023242538A1PanK Modulators and Methods Using SameUNIV YALE·Filed 2021·Application pending·0 cites
- 3744US2019151289A1Identification of Small Molecule Inhibitors of Jumonji AT-Rich Interactive Domain 1A (JARID1A) Histone DemethylaseUNIV YALE·Filed 2017·Application pending·0 cites
- 3844US2007191333A1Antibacterial agentsWARNER LAMBERT CO·Filed 2004·Application pending·0 cites
- 3935US6624166B1Pyridazines as interleukin-1β converting enzyme inhibitorsVERTEX PHARMA·Filed 1996·Granted Sep 23, 2003·1 cites·10 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →